- Home
- SISI
SISI
Shineco Inc.
as 11-22-2024 3:39pm EST
Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.
| Founded: | 1997 | Country: | China |
| Employees: | N/A | City: | CHAOYANG DISTRICT, BEIJING, |
| Market Cap: | 5.9M | IPO Year: | 2016 |
| Target Price: | N/A | AVG Volume (30 days): | 159.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -73.78 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.24 - $117.65 | Next Earning Date: | 11-14-2024 |
| Revenue: | $10,330,284 | Revenue Growth: | 370.34% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Shineco Inc. News
SISI Breaking Stock News: Dive into SISI Ticker-Specific Updates for Smart Investing
GlobeNewswire
10 days ago
Shineco Announces Reverse Split to Regain NASDAQ Compliance
TipRanks
a month ago
Shineco Approves Key Proposals at 2025 AGM
GlobeNewswire
4 months ago
Shineco Announces Closing of $2 Million Underwritten Public Offering
GlobeNewswire
4 months ago
Shineco Announces Pricing of $2 Million Underwritten Public Offering
GlobeNewswire
4 months ago
Shineco Announces Proposed Underwritten Public Offering
GlobeNewswire
4 months ago
Shineco Announces New Distribution Agreements for over $30 Million in Sales for its New Health Food Beverage
GlobeNewswire
5 months ago
Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire
5 months ago
Shineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of $7.0 Million
Compare SISI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SISI Shineco Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.